EVH EVOLENT HEALTH INC revenue, earnings and financials
For the quarter ended June 30, 2026, EVOLENT HEALTH INC reported revenue of $653M (up 46.9% from a year earlier), net income of −$28.4M and diluted EPS of −$0.25; over the last four quarters revenue was $2.10B and net income −$505M; for the fiscal year ended December 2025 revenue was $1.88B, down 26.6% on the year before.
EVH annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.88B, gross profit n/a, operating income −$410M, net income −$579M (margin -30.9%), EPS −$5.07
- Fiscal year ended Dec 2024: revenue $2.55B, gross profit n/a, operating income −$40.5M, net income −$93.5M (margin -3.7%), EPS −$0.81
- Fiscal year ended Dec 2023: revenue $1.96B, gross profit n/a, operating income −$71.2M, net income −$142M (margin -7.2%), EPS −$1.28
- Fiscal year ended Dec 2022: revenue $1.35B, gross profit n/a, operating income $3.64M, net income −$19.2M (margin -1.4%), EPS −$0.20
- Fiscal year ended Dec 2021: revenue $908M, gross profit n/a, operating income −$42.4M, net income −$37.6M (margin -4.1%), EPS −$0.44
EVH quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $653M (up 46.9% year over year), net income −$28.4M, EPS −$0.25
- Quarter ended Mar 31, 2026: revenue $496M (up 2.6% year over year), net income −$26.6M, EPS −$0.24
- Quarter ended Dec 31, 2025: revenue $469M (down 27.5% year over year), net income −$429M, EPS −$3.84
- Quarter ended Sep 30, 2025: revenue $480M (down 22.8% year over year), net income −$20.9M, EPS −$0.24
- Quarter ended Jun 30, 2025: revenue $444M (down 31.3% year over year), net income −$19.9M, EPS −$0.44
- Quarter ended Mar 31, 2025: revenue $484M (down 24.4% year over year), net income −$64.6M, EPS −$0.63
- Quarter ended Dec 31, 2024: revenue $647M (up 16.3% year over year), net income −$22.8M, EPS −$0.27
- Quarter ended Sep 30, 2024: revenue $621M (up 21.6% year over year), net income −$23.1M, EPS −$0.27
- Quarter ended Jun 30, 2024: revenue $647M (up 37.9% year over year), net income $1.60M, EPS −$0.06
- Quarter ended Mar 31, 2024: revenue $640M (up 49.6% year over year), net income −$17.3M, EPS −$0.22
- Quarter ended Dec 31, 2023: revenue $556M (up 45.4% year over year), net income −$33.4M, EPS −$0.36
- Quarter ended Sep 30, 2023: revenue $511M (up 44.9% year over year), net income −$25.3M, EPS −$0.30
- Quarter ended Jun 30, 2023: revenue $469M (up 46.6% year over year), net income −$34.3M, EPS −$0.37
- Quarter ended Mar 31, 2023: revenue $428M (up 44.0% year over year), net income −$20.0M, EPS −$0.24
- Quarter ended Dec 31, 2022 (from the annual report): revenue $382M (up 54.0% year over year), net income −$11.4M, EPS −$0.11
- Quarter ended Sep 30, 2022: revenue $353M (up 58.5% year over year), net income $2.12M, EPS $0.02
- Quarter ended Jun 30, 2022: revenue $320M (up 44.1% year over year), net income −$4.59M, EPS −$0.05
- Quarter ended Mar 31, 2022: revenue $297M (up 38.1% year over year), net income −$5.35M, EPS −$0.06
- Quarter ended Dec 31, 2021 (from the annual report): revenue $248M, net income −$5.65M, EPS −$0.06
- Quarter ended Sep 30, 2021: revenue $222M, net income −$13.0M, EPS −$0.15
EVH cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $38.8M, share buybacks $40.0M
- Fiscal year ended Dec 2024: operating cash flow $18.8M, share buybacks $0
- Fiscal year ended Dec 2023: operating cash flow $143M, share buybacks $0
- Fiscal year ended Dec 2022: operating cash flow −$11.6M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow $38.7M, share buybacks n/a
EVH balance sheet
- Jun 30, 2026: cash $116M, total assets $1.97B, total liabilities $1.59B, shareholders' equity $383M, long-term debt $966M
- Mar 31, 2026: cash $142M, total assets $1.88B, total liabilities $1.48B, shareholders' equity $396M, long-term debt $973M
- Dec 31, 2025: cash $152M, total assets $1.90B, total liabilities $1.48B, shareholders' equity $415M, long-term debt $971M
- Sep 30, 2025: cash $117M, total assets $2.45B, total liabilities $1.61B, shareholders' equity $842M, long-term debt $1.05B
- Jun 30, 2025: cash $151M, total assets $2.46B, total liabilities $1.34B, shareholders' equity $896M, long-term debt $648M
- Mar 31, 2025: cash $247M, total assets $2.65B, total liabilities $1.52B, shareholders' equity $936M, long-term debt $648M
- Dec 31, 2024: cash $104M, total assets $2.54B, total liabilities $1.35B, shareholders' equity $1.00B, long-term debt $491M
- Sep 30, 2024: cash $96.6M, total assets $2.50B, total liabilities $1.28B, shareholders' equity $1.04B, long-term debt $600M
What is EVH's revenue?
EVOLENT HEALTH INC reported $2.10B of revenue over its last four quarters, through June 30, 2026.
Is EVH profitable?
No. EVOLENT HEALTH INC lost $505M over the last four quarters.
What is EVH's EPS?
Diluted earnings per share over the last four quarters were −$4.57; −$0.25 in the latest quarter.